Title 17 Clean Energy Financing Program Expansion
Sector: Nuclear • Location: United States
Source: Department of Energy (.gov)
Expansion of the Title 17 Clean Energy Financing Program with an additional $40 billion of loan authority for projects eligible under section 1703 of the Energy Policy Act of 2005, including fossil energy and nuclear energy projects, to remain available through September 30, 2026.
- Status
- Prospective
- Sector
- Nuclear
- Location
- United States of America
- Updated
- 22 Jul 2026
- Source
- Department of Energy (.gov)
ConstructChat
Ask ConstructChat about Title 17 Clean Energy Financing Program Expansion
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Expansion of the Title 17 Clean Energy Financing Program with an additional $40 billion of loan authority for projects eligible under section 1703 of the Energy Policy Act of 2005, including fossil energy and nuclear energy projects, to remain available through September 30, 2026. |
Original sector | Energy |
Budget |
Location
Country | United States of America (USA) |
Source
Source | Department of Energy (.gov) |
URL |
More Details
Record type | Project |
Sector | Nuclear |
Article published date | 2026-05-11 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Nuclear projects in United States
- Solar reforming of CO2 to produce Diesel fuel
- Seymour Biodiesel Refinery and Biodiesel Production Plant, USA
- PepsiCo Frito-Lay Chip Production Facility, Arizona
- Malt-O-Meal Breakfast Cereal
- Port Charlotte Distillery, Islay, Scotland
- Sunnymel Poultry Slaughterhouse
- ChemSyn (Aptuit) Pharmaceutical Manufacturing Plant
- SAFC Pharma St Louis Facility, Missouri
